Summit Therapeutics IncNASDAQ:SMMT
- LAST PRICE4.3200
- TODAY'S CHANGE (%)-0.0700 (-1.5945%)
- Bid / Lots4.2700/ 1
- Ask / Lots4.4500/ 1
- Open / Previous Close4.4100 / 4.3900
- Day Range
- 52 Week Range
- Volume1,979,398
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | SMMT |
|---|---|---|
| 09:32 ET | 14328 | 4.4 |
| 09:34 ET | 600 | 4.32 |
| 09:36 ET | 2616 | 4.33 |
| 09:38 ET | 2830 | 4.35 |
| 09:39 ET | 3780 | 4.37 |
| 09:41 ET | 3444 | 4.35 |
| 09:43 ET | 7138 | 4.33 |
| 09:45 ET | 5614 | 4.33 |
| 09:48 ET | 3178 | 4.315 |
| 09:50 ET | 2413 | 4.315 |
| 09:52 ET | 715 | 4.3141 |
| 09:54 ET | 2325 | 4.32 |
| 09:56 ET | 403 | 4.33 |
| 09:57 ET | 3000 | 4.34 |
| 09:59 ET | 7463 | 4.33 |
| 10:01 ET | 1169 | 4.325 |
| 10:03 ET | 5274 | 4.335 |
| 10:06 ET | 754 | 4.335 |
| 10:08 ET | 1136 | 4.33 |
| 10:10 ET | 1239 | 4.32 |
| 10:12 ET | 714 | 4.33 |
| 10:14 ET | 736 | 4.34 |
| 10:15 ET | 9539 | 4.345 |
| 10:17 ET | 1453 | 4.345 |
| 10:19 ET | 300 | 4.345 |
| 10:21 ET | 5375 | 4.305 |
| 10:24 ET | 16017 | 4.27 |
| 10:26 ET | 762 | 4.275 |
| 10:28 ET | 2837 | 4.275 |
| 10:30 ET | 8224 | 4.29 |
| 10:32 ET | 211 | 4.2803 |
| 10:33 ET | 796 | 4.29 |
| 10:35 ET | 500 | 4.28 |
| 10:37 ET | 1125 | 4.295 |
| 10:39 ET | 598 | 4.305 |
| 10:42 ET | 1200 | 4.305 |
| 10:44 ET | 3434 | 4.285 |
| 10:46 ET | 200 | 4.285 |
| 10:48 ET | 9176 | 4.285 |
| 10:50 ET | 20569 | 4.275 |
| 10:51 ET | 1270 | 4.27 |
| 10:53 ET | 1586 | 4.275 |
| 10:55 ET | 1550 | 4.2801 |
| 10:57 ET | 1035 | 4.275 |
| 11:00 ET | 477 | 4.275 |
| 11:02 ET | 944 | 4.285 |
| 11:04 ET | 3242 | 4.305 |
| 11:06 ET | 100 | 4.305 |
| 11:08 ET | 1119 | 4.305 |
| 11:09 ET | 1041 | 4.3 |
| 11:11 ET | 1800 | 4.315 |
| 11:13 ET | 914 | 4.315 |
| 11:15 ET | 400 | 4.3149 |
| 11:18 ET | 1400 | 4.3194 |
| 11:20 ET | 991 | 4.31 |
| 11:22 ET | 10061 | 4.315 |
| 11:24 ET | 6111 | 4.34 |
| 11:26 ET | 253348 | 4.305 |
| 11:27 ET | 7569 | 4.29 |
| 11:29 ET | 1498 | 4.29 |
| 11:31 ET | 5018 | 4.31 |
| 11:33 ET | 300 | 4.325 |
| 11:36 ET | 400 | 4.31 |
| 11:38 ET | 1261 | 4.315 |
| 11:40 ET | 1401 | 4.31 |
| 11:42 ET | 3389 | 4.3197 |
| 11:44 ET | 456 | 4.325 |
| 11:45 ET | 678 | 4.315 |
| 11:47 ET | 345 | 4.32 |
| 11:49 ET | 1126 | 4.315 |
| 11:51 ET | 504 | 4.315 |
| 11:56 ET | 276 | 4.315 |
| 12:00 ET | 275 | 4.315 |
| 12:02 ET | 100 | 4.315 |
| 12:03 ET | 130 | 4.3101 |
| 12:05 ET | 1692 | 4.315 |
| 12:07 ET | 371 | 4.315 |
| 12:09 ET | 434 | 4.315 |
| 12:12 ET | 10177 | 4.305 |
| 12:14 ET | 320 | 4.305 |
| 12:16 ET | 228 | 4.305 |
| 12:18 ET | 100 | 4.305 |
| 12:20 ET | 2425 | 4.305 |
| 12:21 ET | 400 | 4.305 |
| 12:23 ET | 1635 | 4.315 |
| 12:25 ET | 230 | 4.32 |
| 12:27 ET | 3491 | 4.335 |
| 12:30 ET | 527 | 4.34 |
| 12:32 ET | 543 | 4.335 |
| 12:34 ET | 100 | 4.3325 |
| 12:36 ET | 1030 | 4.335 |
| 12:38 ET | 548 | 4.335 |
| 12:39 ET | 336 | 4.3325 |
| 12:41 ET | 18303 | 4.33 |
| 12:43 ET | 6173 | 4.325 |
| 12:45 ET | 2006 | 4.315 |
| 12:48 ET | 5428 | 4.315 |
| 12:50 ET | 1621 | 4.3092 |
| 12:52 ET | 700 | 4.3 |
| 12:54 ET | 100 | 4.3 |
| 12:56 ET | 2201 | 4.295 |
| 12:57 ET | 500 | 4.295 |
| 12:59 ET | 7451 | 4.295 |
| 01:01 ET | 2431 | 4.3 |
| 01:03 ET | 697 | 4.31 |
| 01:06 ET | 3400 | 4.315 |
| 01:08 ET | 400 | 4.315 |
| 01:10 ET | 1700 | 4.315 |
| 01:12 ET | 339 | 4.315 |
| 01:14 ET | 117157 | 4.385 |
| 01:15 ET | 67453 | 4.375 |
| 01:17 ET | 21674 | 4.385 |
| 01:19 ET | 5804 | 4.38 |
| 01:21 ET | 6447 | 4.395 |
| 01:24 ET | 8922 | 4.395 |
| 01:26 ET | 20903 | 4.3863 |
| 01:28 ET | 6971 | 4.4 |
| 01:30 ET | 25205 | 4.405 |
| 01:32 ET | 43353 | 4.355 |
| 01:33 ET | 3120 | 4.325 |
| 01:35 ET | 3023 | 4.33 |
| 01:37 ET | 800 | 4.325 |
| 01:39 ET | 1717 | 4.33 |
| 01:42 ET | 3191 | 4.315 |
| 01:44 ET | 1400 | 4.3125 |
| 01:46 ET | 735 | 4.315 |
| 01:48 ET | 1000 | 4.325 |
| 01:50 ET | 1884 | 4.325 |
| 01:51 ET | 1961 | 4.325 |
| 01:53 ET | 1450 | 4.325 |
| 01:55 ET | 1384 | 4.325 |
| 01:57 ET | 13195 | 4.35 |
| 02:00 ET | 32272 | 4.33 |
| 02:02 ET | 600 | 4.33 |
| 02:04 ET | 1300 | 4.33 |
| 02:06 ET | 11708 | 4.32 |
| 02:08 ET | 29493 | 4.34 |
| 02:09 ET | 5166 | 4.35 |
| 02:11 ET | 1495 | 4.32 |
| 02:13 ET | 3477 | 4.33 |
| 02:15 ET | 781 | 4.33 |
| 02:18 ET | 878 | 4.315 |
| 02:20 ET | 14081 | 4.29 |
| 02:22 ET | 2623 | 4.2898 |
| 02:24 ET | 5204 | 4.28 |
| 02:26 ET | 651 | 4.275 |
| 02:27 ET | 1100 | 4.275 |
| 02:29 ET | 1680 | 4.275 |
| 02:31 ET | 2425 | 4.28 |
| 02:33 ET | 400 | 4.2758 |
| 02:36 ET | 1969 | 4.275 |
| 02:38 ET | 1212 | 4.265 |
| 02:40 ET | 597 | 4.2698 |
| 02:42 ET | 822 | 4.265 |
| 02:44 ET | 1324 | 4.26 |
| 02:45 ET | 5665 | 4.29 |
| 02:47 ET | 3743 | 4.285 |
| 02:49 ET | 2090 | 4.275 |
| 02:51 ET | 1323 | 4.28 |
| 02:54 ET | 2103 | 4.275 |
| 02:56 ET | 3932 | 4.275 |
| 02:58 ET | 723 | 4.275 |
| 03:00 ET | 501 | 4.28 |
| 03:02 ET | 5760 | 4.3 |
| 03:03 ET | 4114 | 4.285 |
| 03:05 ET | 307 | 4.29 |
| 03:07 ET | 7602 | 4.275 |
| 03:09 ET | 3474 | 4.285 |
| 03:12 ET | 2176 | 4.285 |
| 03:14 ET | 576 | 4.29 |
| 03:16 ET | 1669 | 4.29 |
| 03:18 ET | 4554 | 4.315 |
| 03:20 ET | 3119 | 4.31 |
| 03:21 ET | 6434 | 4.33 |
| 03:23 ET | 4677 | 4.325 |
| 03:25 ET | 4073 | 4.325 |
| 03:27 ET | 1153 | 4.31 |
| 03:30 ET | 3113 | 4.3 |
| 03:32 ET | 3590 | 4.3051 |
| 03:34 ET | 1853 | 4.315 |
| 03:36 ET | 7827 | 4.315 |
| 03:38 ET | 3636 | 4.32 |
| 03:39 ET | 2603 | 4.32 |
| 03:41 ET | 5915 | 4.31 |
| 03:43 ET | 13675 | 4.31 |
| 03:45 ET | 5208 | 4.3086 |
| 03:48 ET | 2938 | 4.305 |
| 03:50 ET | 10825 | 4.325 |
| 03:52 ET | 7061 | 4.33 |
| 03:54 ET | 52839 | 4.32 |
| 03:56 ET | 12674 | 4.33 |
| 03:57 ET | 29124 | 4.32 |
| 03:59 ET | 473398 | 4.32 |
May 7, 2024
DJ Summit Therapeutics Initiated at Buy by Citigroup, from 8:27AM ET on Tuesday May 07, 2024 by Dow Jones
8:27AM ET on Tuesday May 07, 2024 by Dow Jones
May 1, 2024
Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2024, from 7:00AM ET on Wednesday May 01, 2024 by Dow Jones
7:00AM ET on Wednesday May 01, 2024 by Dow Jones*DJ Summit Therapeutics 1Q Loss/Shr 6c >SMMT, from 7:00AM ET on Wednesday May 01, 2024 by Dow Jones
7:00AM ET on Wednesday May 01, 2024 by Dow Jones
Apr 24, 2024
Press Release: Summit Therapeutics to Host First Quarter 2024 Financial Results & Operational Progress Call on May 1, 2024, from 4:46PM ET on Wednesday Apr 24, 2024 by Dow Jones
4:46PM ET on Wednesday Apr 24, 2024 by Dow JonesSummit Therapeutics to Host First Quarter 2024 Financial Results & Operational Progress Call on May 1, 2024, from 4:30PM ET on Wednesday Apr 24, 2024 by Dow Jones
4:30PM ET on Wednesday Apr 24, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Summit Therapeutics Inc | 3.1B | -26.1x | --- |
Vitaspring Biomedical Co. Ltd | 3.1B | 3,311.3x | --- |
Xenon Pharmaceuticals Inc | 2.9B | -14.2x | --- |
Iovance Biotherapeutics Inc | 2.9B | -5.6x | --- |
IDEAYA Biosciences Inc | 3.1B | -19.2x | --- |
SpringWorks Therapeutics Inc | 3.3B | -8.3x | --- |
Company Information
Summit Therapeutics Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of patient, physician and caregiver medicinal therapies. The Company's development candidate is ivonescimab, a potential first-in-class bispecific antibody intending to combine the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects of an anti-VEGF compound into a single molecule. It develops ivonescimab in non-small cell lung cancer (NSCLC), specifically launching Phase III clinical trials in the indications such as ivonescimab combined with chemotherapy in patients with epidermal growth factor receptor (EGFR)-mutated, locally advanced or metastatic non-squamous NSCLC who have progressed after treatment with a third-generation EGFR tyrosine kinase inhibitor (HARMONi), and ivonescimab combined with chemotherapy in first-line metastatic squamous NSCLC patients (HARMONi-3). Its ivonescimab is engineered with Akeso's Tetrabody technology.
Contact Information
- Headquarters
- 2882 Sand Hill Road, Suite 106MENLO PARK, CA, United States 94025
- Phone
- 650-460-8308
- Fax
- 302-655-5049
Executives
- Executive Chairman of the Board, Co-Chief Executive Officer
- Robert Duggan
- President, Co-Chief Executive Officer, Director
- Mahkam Zanganeh
- Chief Financial Officer
- Ankur Dhingra
- Chief Operating Officer, Director
- Manmeet Soni
- Lead Non-Executive Independent Director
- Kenneth Clark
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.1B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 702.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -1.26 |
EPS | $-0.17 |
Book Value | $0.11 |
P/E Ratio | -26.1x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
